Nevertheless, it becomes clear that the epigenetic modulation of ABCG1 is consistently associated with several metabolic disorders, including TG metabolism, diabetes-related traits, T2D risk, obesity and in a lesser degree to CAD (Table 2). Here, ABCG1 is linked to obesity due to melanocortin 4 receptor deficiency.